drug protocol number

D6970C00009

drug sponsor

Astrazeneca

drug study

Baxdrostat

drug trial site

King Abdulaziz Medical City NG (Riyadh), King Khalid University Hospital (Riyadh)

drug status

Ongoing

drug phase